华海清科股份有限公司 审计报告及财务报表 二〇二四年度 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.gov.cn/ 灯出 报告编码: . 华海清科股份有限公司 审计报告及财务报表 (2024 年 01 月 01 日至 2024 年 12 月 31 日止 ) | 目录 | 页次 | | --- | --- | | 审计报告 | 1-6 | | 财务报表 | | | 合并资产负债表和母公司资产负债表 | 1-4 | | 合并利润表和母公司利润表 | ર-6 | | 合并现金流量表和母公司现金流量表 | 7-8 | | 合并所有者权益变动表和母公司所有者权益变动 | 9-12 | | 表 | | | 财务报表附注 | 1-123 | 立信会计师事务所(特殊普通合伙) CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS I 审计报告 信会师报字[2025]第 ZB10934 号 华海清科股份有限公司全体股东: 一、审计意见 我们审计了华海清科股份有限公司(以下简称华海清科)财务报 表,包括 2024 年 12 月 31 日的合并及母 ...

国泰海通证券股份有限公司 关于华海清科股份有限公司 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 公司于 2025 年 4 月 28 日召开了第二届董事会第十三次会议，审议通过了 《关于确认 2024 年度日常关联交易及预计 2025 年度日常关联交易的议案》，关 联董事王同庆、甄佳、陈泰全、王怀需回避表决，此议案获出席会议的非关联 董事一致表决通过，审议程序符合相关法律法规。 公司第二届董事会独立董事专门会议第二次会议审议通过上述议案。全体 独立董事认为，公司 2024 年度已发生及 2025 年度预计发生的日常关联交易事 项为公司开展日常生产经营所需，定价遵循市场公允定价原则，有利于公司经 营业绩的提高，不会对公司财务状况、经营成果产生不利影响，不存在损害公 司及非关联股东尤其是中小股东合法权益的情形，不会对公司独立性产生影响， 不会对关联方形成依赖，因此一致同意该议案。 公司董事会审计委员会已就该事项发表了书面审核意见：公司 2024 年度已 发生及 2025 年度预计发生的日常关联交易遵循公平、公正、公允的定价原则， 定价公允，不会损害公司和全体股东的利益，审议程序和表决程序符合《公司 ...

关于华海清科股份有限公司 2024 年度募集资金存放和使用情况 专项报告的鉴证报告 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.org 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.org 华海清科公司董事会的责任是按照中国证券监督管理委员会《上 市公司监管指引第2号 -- 上市公司募集资金管理和使用的监管要求 (2022年修订)》(证监会公告〔2022〕15号）、《上海证券交易所 科创板上市公司自律监管指引第1号 -- 规范运作》以及《上海证券 交易所上市公司自律监管指南第1号——公告格式》的相关规定编制 募集资金专项报告。这种责任包括设计、执行和维护与募集资金专项 报告编制相关的内部控制,确保募集资金专项报告真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 关于华海清科股份有限公司 2024年度募集资金存放与使用情况 专项报告的鉴证报告 信会师报字[2025]第ZB10937号 华海清科股份有限公司全体股东: 我们接受委托,对后附的华海清科股份有限公司(以下简称"华 海清科公司")2024 ...

Financial Performance - The company's operating revenue for Q1 2025 reached ¥912,498,331.19, representing a 34.14% increase compared to ¥680,248,921.74 in the same period last year[4] - Net profit attributable to shareholders was ¥233,417,322.55, up 15.47% from ¥202,145,758.93 year-on-year[4] - The basic earnings per share increased to ¥0.99, a rise of 16.47% from ¥0.85 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥912.50 million, a 34.1% increase from ¥680.25 million in Q1 2024[18] - Net profit for Q1 2025 was ¥233.42 million, representing a 15.4% increase compared to ¥202.15 million in Q1 2024[19] - Basic earnings per share for Q1 2025 were ¥0.99, compared to ¥0.85 in Q1 2024, reflecting a 16.5% increase[19] - The company reported a total profit of ¥259.99 million for Q1 2025, up from ¥230.06 million in Q1 2024, marking a 12.9% increase[19] Cash Flow and Assets - The net cash flow from operating activities decreased significantly by 92.31%, amounting to ¥12,916,712.88, compared to ¥167,902,222.64 in the previous year[4] - Cash flow from operating activities for Q1 2025 was ¥12.92 million, down 92.3% from ¥167.90 million in Q1 2024[20] - Cash flow from investing activities for Q1 2025 showed a net outflow of ¥335.29 million, compared to a net outflow of ¥87.58 million in Q1 2024[21] - Cash and cash equivalents at the end of Q1 2025 totaled ¥2.32 billion, a decrease from ¥2.48 billion at the end of Q1 2024[21] - The company's current assets totaled RMB 8,611,633,309.82, down from RMB 8,832,012,584.58 at the end of 2024, primarily due to a decrease in cash and cash equivalents[13][15] - The company's cash and cash equivalents decreased to RMB 2,373,573,585.01 from RMB 2,761,029,293.79, a decline of approximately 14.1%[13] Research and Development - Research and development (R&D) expenses totaled ¥107,255,256.76, reflecting a 33.33% increase from ¥80,440,446.19, with R&D expenses accounting for 11.75% of operating revenue[5] - Research and development expenses for Q1 2025 were ¥109.44 million, an increase of 41.2% from ¥77.44 million in Q1 2024[18] - The company plans to continue increasing R&D investment to enhance product development and market competitiveness[8] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,666,230,019.71, a slight decrease of 0.72% from ¥11,750,821,583.13 at the end of the previous year[5] - The company's total assets amounted to RMB 11,666,230,019.71, a slight decrease from RMB 11,750,821,583.13 as of December 31, 2024[13][15] - The company's inventory increased to RMB 3,487,586,141.11 from RMB 3,267,533,611.78, indicating a growth of approximately 6.7%[13][15] - The total liabilities decreased to RMB 4,938,417,261.83 from RMB 5,270,511,451.80, reflecting a reduction of about 6.3%[15] - The company's equity attributable to shareholders rose to RMB 6,727,812,757.88 from RMB 6,473,073,313.93, marking an increase of approximately 3.9%[15] - The company's short-term borrowings decreased to RMB 24,549,992.35 from RMB 27,501,155.54, a decline of about 7.1%[15] - The accounts receivable increased to RMB 698,094,219.91 from RMB 663,535,781.06, representing a growth of approximately 5.2%[13] - The company's long-term equity investments increased to RMB 248,617,490.64 from RMB 223,649,216.82, showing an increase of about 11.2%[14] - The company reported a significant increase in other non-current financial assets to RMB 61,004,432.40 from RMB 43,850,566.27, reflecting a growth of about 39.1%[14] Market Performance - The company has seen a significant increase in market share and sales scale for CMP products, contributing to the revenue growth[8] - The company reported a decrease in other comprehensive income, with a net amount of -¥705,840.99 in Q1 2025 compared to -¥756,947.28 in Q1 2024[19]

Financial Performance - The company achieved a net profit attributable to shareholders of 1,023,407,865.85 CNY for the fiscal year 2024[5]. - The proposed cash dividend is 5.50 CNY per 10 shares (including tax), totaling 129,916,524.10 CNY, which represents 12.69% of the net profit[6]. - As of December 31, 2024, the company's distributable profits amounted to 2,134,753,598.61 CNY[5]. - The company's revenue for 2024 reached CNY 3,406,228,610.47, representing a 35.82% increase compared to CNY 2,507,991,057.37 in 2023[24]. - Net profit attributable to shareholders for 2024 was CNY 1,023,407,865.85, up 41.40% from CNY 723,746,551.15 in 2023[24]. - The net cash flow from operating activities increased by 76.83% to CNY 1,154,609,605.58 in 2024, compared to CNY 652,931,193.42 in 2023[24]. - Total assets as of the end of 2024 were CNY 11,750,821,583.13, a 28.88% increase from CNY 9,117,359,632.14 at the end of 2023[24]. - Basic earnings per share for 2024 were CNY 4.33, reflecting a 41.50% increase from CNY 3.06 in 2023[25]. - The company's operating revenue increased by 35.82% year-on-year, reaching 3.406 billion RMB, while net profit attributable to shareholders grew by 41.40% to 1.023 billion RMB[26]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 856.18 million yuan, reflecting a growth of 40.79%[51]. Research and Development - The company's R&D expenditure as a percentage of revenue was 11.56% in 2024, a decrease of 0.56 percentage points from 12.12% in 2023[25]. - The company’s R&D investment for 2024 reached RMB 393.77 million, a year-on-year increase of 29.56%[54]. - The proportion of R&D investment to operating revenue decreased to 11.56%, down by 0.56 percentage points from the previous year[97]. - The company has a total of 634 R&D personnel, accounting for 33.07% of the total workforce[105]. - The company is currently working on 20 R&D projects with a total expected investment of CNY 90,121,500[99]. - The company has successfully developed key technologies such as nano-level polishing and big data analysis, enhancing its technological innovation capabilities[103]. - The company has established a comprehensive intellectual property protection system covering core technologies, forming a strong patent portfolio[55]. - The company obtained 66 new intellectual property rights during the reporting period, bringing the total to 557[93]. Market Strategy and Expansion - The company plans to continue expanding its market presence and investing in new technologies[16]. - The company is focused on enhancing its product offerings and exploring potential mergers and acquisitions to drive growth[16]. - The company is actively developing cleaning equipment for SiC and large silicon wafers, with successful sales achieved during the reporting period[45]. - The company is focusing on the development of compound semiconductors like SiC and GaN, anticipating unprecedented market growth in these areas[88]. - The company is exploring market expansion opportunities, particularly in emerging markets, to diversify its revenue streams[177]. - Market expansion plans include entering two new international markets by Q3 2024, projected to increase user base by 20%[178]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $100 million allocated for this purpose[179]. Governance and Compliance - The company has received a standard unqualified audit opinion from its accounting firm[5]. - The company emphasizes that forward-looking statements do not constitute substantive commitments to investors[7]. - The company has confirmed that there are no violations of decision-making procedures regarding external guarantees[8]. - The company has established a governance structure that complies with relevant laws and regulations, ensuring effective operation and independent decision-making[172]. - The company has engaged in daily related transactions with Tianfu Qingyuan Holdings Group, indicating ongoing strategic partnerships[174]. - The company has a diverse portfolio of board members with extensive experience across various sectors, contributing to its strategic decision-making[183]. Operational Risks and Challenges - The company has outlined various operational risks and corresponding mitigation strategies in the report[3]. - The company faces risks related to the loss of core technical personnel and the need for continuous talent acquisition to maintain its competitive edge[112]. - The company is at risk of high customer concentration, which may affect its negotiating power and overall business performance[114]. - The semiconductor equipment industry is sensitive to macroeconomic fluctuations, which could affect market demand[119]. - Changes in government subsidies and tax incentives could adversely impact the company's financial performance[120]. Product Development and Innovation - The company launched a new polishing system architecture CMP machine Universal-H300, which has received bulk repeat orders and achieved scale shipments[38]. - The company has successfully developed dedicated CMP equipment for third-generation semiconductor clients, marking a significant technological advancement[38]. - The CMP equipment developed by the company features advanced polishing systems and cleaning technologies, meeting the increasing cleanliness requirements in manufacturing processes[60]. - The company has developed advanced 12-inch thinning and polishing equipment, integrating ultra-precision grinding and CMP processes, which significantly meets the demand for wafer thinning technology in high-end markets such as 3D IC manufacturing[63]. - The company has made significant progress in reducing reliance on imported high-precision thinning and cutting equipment, addressing supply chain security concerns[83]. Financial Management - The company has implemented a stock incentive plan covering core management and technical personnel, enhancing loyalty and cohesion within the core team[56]. - The company has repurchased a total of 513,031 shares, with a total payment of RMB 79,919,185.00, to maintain stock price and boost investor confidence[58]. - The company’s total liabilities include accounts payable of CNY 1,042,981,412.51, which increased by 50.23% due to higher procurement costs[151]. - The company’s financial expenses improved by 30.44%, resulting in a net financial income of CNY -23,538,049.32, primarily due to interest income from deposits[147]. Customer Engagement and Satisfaction - Customer satisfaction metrics have shown improvement, with a reported increase of 15% in positive feedback from users[177]. - The company has a dedicated after-sales service team covering over 150 customer groups, ensuring rapid response to customer needs[110]. - The company is committed to maintaining transparency in its governance structure and regularly updates its stakeholders through announcements on the Shanghai Stock Exchange[181].

华海清科股份有限公司 2024 年度独立董事述职报告 本人作为华海清科股份有限公司（以下简称"公司"）的独立董事，严格按 照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）和《上市公司独立董事管理办法》等有关法律法规的 要求，以及《公司章程》等相关制度，认真负责、忠实勤勉地履行了独立董事的 义务和职责，积极出席相关会议，认真审议董事会各项议案，对公司重大事项发 表了独立意见，切实维护公司和全体股东尤其是中小股东的合法权益。现将本人 2024 年度履职情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 金玉丰，男，1961 年生，中国国籍，新加坡永久居留权，毕业于东南大学 物理电子与光电子专业，博士研究生学历。1985 年 4 月至 1999 年 3 月任电子部 第 55 研究所工程师；1999 年 4 月至 2001 年 3 月任北京大学微电子所博士后； 2001 年 4 月至 2006 年 7 月任北京大学微电子所副教授；2006 年 8 月至 2024 年 6 月任北京大学微电子院教授；2014 年 2 月至 2024 ...

华海清科股份有限公司 2024 年度独立董事述职报告 本人作为华海清科股份有限公司（以下简称"公司"）的独立董事，严格按 照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）和《上市公司独立董事管理办法》等有关法律法规的 要求，以及《公司章程》等相关制度，认真负责、忠实勤勉地履行了独立董事的 义务和职责，积极出席相关会议，认真审议董事会各项议案，对公司重大事项发 表了独立意见，切实维护公司和全体股东尤其是中小股东的合法权益。现将本人 2024 年度履职情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 李全，男，1976 年生，中国国籍，无境外永久居留权，毕业于南开大学西 方经济学专业，博士研究生学历。2004 年 7 月至 2006 年 8 月任财政部财政科学 研究所博士后；2006 年 8 月至 2017 年 7 月历任财政部中国财政科学研究院会计 学专业助理研究员、副研究员、研究员；2017 年 8 月至今任南开大学金融学院 教授；2020 年 3 月至今任公司独立董事。 （二）是否存在影响独立性的情况说明 作为公司的独 ...

华海清科股份有限公司 2024 年度独立董事述职报告 本人作为华海清科股份有限公司（以下简称"公司"）的独立董事，严格按 照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）和《上市公司独立董事管理办法》等有关法律法规的 要求，以及《公司章程》等相关制度，认真负责、忠实勤勉地履行了独立董事的 义务和职责，积极出席相关会议，认真审议董事会各项议案，对公司重大事项发 表了独立意见，切实维护公司和全体股东尤其是中小股东的合法权益。现将本人 2024 年度履职情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 作为公司的独立董事，我本人及直系亲属、主要社会关系均不在公司或其附 属企业任职，未在公司主要股东单位担任任何职务，也未在公司关联企业任职； 没有为公司或其附属企业提供财务、法律、咨询等服务。我具备《上市公司独立 董事管理办法》《公司章程》等相关制度所要求的独立性，能够确保客观、独立 的专业判断，不存在任何影响独立性的情况。 二、独立董事年度履职概况 （一）出席会议情况 管荣齐,男，1967 年生，中国国籍，无境外永久居留权，毕业 ...

华海清科股份有限公司 董事会对独立董事独立性自查情况的专项意见 经核查：公司独立董事金玉丰先生、李全先生、管荣齐先生的任职情况以及 其签署的相关自查情况报告，上述人员不存在任何妨碍其进行独立客观判断的关 系，不存在影响独立董事独立性的情况。因此，董事会认为公司独立董事符合《上 市公司独立董事管理办法》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》中对独立董事独立性的相关要求。 华海清科股份有限公司 董 事 会 2025 年 4 月 28 日 根据证监会《上市公司独立董事管理办法》《上海证券交易所科创板股票上 市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等相关要求，华海清科股份有限公司（以下简称"公司"）董事会，就公司独立 董事金玉丰先生、李全先生、管荣齐先生的独立性情况进行评估并出具如下专项 意见： ...

华海清科公告，2024年营业收入34.06亿元，同比增长35.82%。归属于上市公司股东的净利润10.23亿 元，同比增长41.40%。公司第二届董事会第十三次会议审议通过了《关于公司<2024年度利润分配及资 本公积金转增股本预案>的议案》，拟以实施权益分派股权登记日登记的总股本扣减公司回购专用证券 账户中的股份为基数，每10股派发现金红利5.5元(含税)，以资本公积金向全体股东每10股转增4.9股。 ...